
Megatil 25mg/ml Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Chlorpromazine (25mg/ml)
Overview Megatil 25mg/ml Injection
Solutia 25mg/ml Injection treats diverse conditions including schizophrenia and related psychoses (e.g., paranoia, characterized by delusions and intense anxiety; mania, involving hyperactivity; anxiety; agitation; and risky impulsivity). It's also indicated for managing intractable hiccups, nausea, and autism spectrum disorder. Solutia, a phenothiazine impacting the central nervous system, modifies thought patterns and improves mood, fostering enhanced cognitive, emotional, and behavioral function. Administered intravenously by a healthcare professional, Solutia should be taken consistently at the prescribed time to ensure therapeutic levels. Follow your physician's dosage and duration instructions; if a dose is missed, take it immediately. Complete the entire course, even with symptom improvement; abrupt cessation is unsafe and may exacerbate symptoms. Common side effects include xerostomia, abnormal involuntary movements, urinary retention, constipation, and muscle stiffness. Postural hypotension (sudden blood pressure drops upon standing) may occur initially; rise slowly. Drowsiness and dizziness are possible; avoid activities requiring alertness until effects are known. Weight gain is a potential side effect; maintain a healthy diet and exercise. Injection site reactions (pain, redness, swelling) are typically transient. Report persistent or bothersome side effects to your doctor. Prior to treatment, disclose all existing medical conditions. Solutia is contraindicated in patients with bone marrow suppression, pheochromocytoma, hepatic failure or active liver disease, and central nervous system depression. Diabetics should monitor blood glucose levels closely. Inform your doctor of all medications currently in use due to potential drug interactions.
Primary Ingredients of Megatil 25mg/ml Injection
The provided text is "undefined," which lacks meaning and cannot be rephrased. No meaningful rewriting is possible.
Uses of Megatil 25mg/ml Injection
Managing Anxiety, Mania, and Schizophrenia
Major Benefits of Megatil 25mg/ml Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Megatil 25mg/ml Injection:
- Sleepiness
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Dryness in mouth
- Abnormality of voluntary movements
- Weight gain
- Increased prolactin level in blood
- Urinary retention
- Constipation
- Muscle stiffness
- Injection site reactions (pain, swelling, redness)
- Photophobia
- Blurred vision
How to use Megatil 25mg/ml Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Megatil 25mg/ml Injection works:
Dopamine receptor antagonist Megatil, administered as a 25mg/ml injection, is a standard antipsychotic medication. Its mechanism of action involves inhibiting dopamine neurotransmission, a key brain chemical influencing emotional state and cognition.
SAFETY ADVICE
AlcoholUNSAFE
Combining Megatil 25mg/ml Injection and alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
Administering Megatil 25mg/ml Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Megatil 25mg/ml Injection while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant. If this injection is necessary, carefully observe the infant for somnolence.
DrivingUNSAFE
Administering Megatil 25mg/ml Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving is discouraged if these effects manifest.
KidneySAFE IF PRESCRIBED
Megatil 25mg/ml Injection poses no safety concerns for patients with kidney impairment; dose modification isn't necessary. Nevertheless, disclose any pre-existing kidney conditions to your physician. Close medical supervision during treatment is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Megatil 25mg/ml Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Megatil 25mg/ml Injection :
NA
Facts to Know About Megatil 25mg/ml Injection
| Label | Value |
|---|---|
| Chemical Type | Phenothiazine-based compound |
| Developing Habits | No. |
| Type of Therapy | Neuroscience of the Central Nervous System |
